Matthew Autterson has spent the past two decades working in the financial services industry. Here, he held the position of the president in a prestigious chartered financial institution in the United States. His relentless efforts at Michigan State University earned him a B.A in Finance in 1980. Subsequently, Matthew Autterson joined the University of Denver where he graduated with a degree in Tax Program.
Matthew Autterson landed his first job at a subsidiary of Fiserv, First Trust Corporation. In 1982, he teamed up with his business partners to form a chartered trust company in Colorado. It would operate as a subsidiary of Integrated Resources, which is a New York-based financial institution. Over time, he worked his way up to become the president of Resources Trust Company in 1986. Three years later, Integrated Resources, Inc., acquired Resources Trust Company along with its assets in 1989. Integrated Resources, Inc. changed its name to SunAmerica, Inc., which was in 1989 acquired by AIG for $18 billion.
In May 2001, Fiserv acquired Resource Trust Company from AIG. Before the acquisition, Resource Trust Company ranked as the largest state-chartered depository trust company in the United States. Resources Trust Company had provided over 200,000 clients with custodial and depository services. It currently has over 15,000 registered independent financial advisors. Resources Trust Company had 700 employees and more than $1 billion in deposits and $20 billion in custodial assets before completion of the sale. See This Article for additional information
Matthew Autterson currently works at Falci Adaptive Biosystems (FAB) and is a member of its Board of Directors. In its capacity as a business leader in Colorado, FAB reflects Matthew Autterson’s commitment to philanthropy. He has held many leadership roles including Denver Hospice’s Chairman of the Board of Directors, the Board of the Denver Zoo, the Webb-Waring Foundation, and the Denver Zoological Foundation. He previously served on the boards of World Presidents Organization and the Young Presidents Organization. Matthew Autterson currently works at CNS Bioscience, which is a clinical-stage drug manufacturer founded in 2013 by Scott Falci. The firm focuses on neuropathic pain. Here, Mr. Autterson assumes the role of the President, Chief Executive Officer as well as a Board Member. As a nonprofit organization, Falci Adaptive Biosystems dedicates to helping people living with neuromotor conditions increase their mobility and their ability to control their surroundings. Its headquarters is located in Englewood in Colorado. It focuses on the manufacturing of human-machine interface to help physically disabled increase their ability to control their environment.